BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like Medidata Solutions, Inc. Successfully Hosts Annual Conference Series July 12, 2017 <b>Joe Ryan</b> Joins <b>BIT Group</b> As Vice President Business Development February 19, 2017 3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven July 4, 2017